Brief: Cohance Lifesciences March-Quarter Consol Net Profit 195.5 Million Rupees
12/05/2026 13:09
May 12 (Reuters) - Cohance Lifesciences Ltd COHA.NS: COHANCE LIFESCIENCES LTD MARCH-QUARTER CONSOL NET PROFIT 195.5 MILLION RUPEES COHANCE LIFESCIENCES LTD MARCH-QUARTER CONSOL REVENUE FROM OPERATIONS 6.19 BILLION RUPEES Source text: [ID:] Further company coverage: COHA.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Cohance Lifesciences
See all newsBrief: Cohance Lifesciences Names Abhimanyu Ojha As CFO
Brief: Cohance Lifesciences Says U.S. FDA Issues Form 483 With Five Observations For Jaggaiahpet Unit In Andhra Pradesh
India's Cohance Lifesciences falls after US FDA inspection at Telangana plant
Brief: Cohance Lifesciences Says Investment Of USD 18 Million In NJ Bio And Aruka Bio
India's Cohance Lifesciences climbs on second-half growth outlook despite Q1 loss